https://www.prnewswire.com/news-releases/cytrx-announces-partial-clinical-hold-affecting-aldoxorubicin-clinical-trials-283026111.html
CytRx Announces Partial Clinical Hold Affecting Aldoxorubicin Clinical Trials
/PRNewswire/ -- CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that the...
announcespartialclinicalholdaffecting
https://www.fiercebiotech.com/keyword/cytrx
CytRx | Fierce Biotech
fiercebiotech